COMMUNIQUÉS West-GlobeNewswire

SRx Health Solutions Announces Intention to Create Subsidiary for Crypto-Based Borrowing
09/05/2025
Proposed subsidiary will borrow Solana, Bitcoin and other cryptocurrencies to leverage its existing assets TAMPA, Fla., May 09, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), [...]
Nelipak® Healthcare Packaging to Expand Operations in Costa Rica
09/05/2025
New production site will enhance Nelipak’s capacity and capabilities to support the Costa Rica life sciences hub CRANSTON, R.I., May 09, 2025 (GLOBE NEWSWIRE) -- Nelipak ® Corporation (“Nelipak ® ”), a leading global [...]
Safest Steroids - Best Legal Steroids For Muscle Growth (Bulking & Cutting) By CrazyBulk USA
09/05/2025
New York City, NY, May 09, 2025 (GLOBE NEWSWIRE) -- In bodybuilding, wanting to get significant growth of strength and muscle in a really short period of time will make the user resort to anabolic steroids. The ensuing [...]
4 Best Fat Burners for Women Over the Counter and Online 2025 - Top Fat Burning Supplements and Pills for Female Weight Loss - Wolfson Brands
09/05/2025
Glasgow, May 09, 2025 (GLOBE NEWSWIRE) -- Losing weight can be tough, especially when stubborn fat just doesn’t seem to budge. But here’s the good news: 2025 brings a new wave of powerful, over-the-counter fat burners [...]
PhenQ Review 2025: Does It Really Work For Weight Loss? Ingredients, Side Effects & Real Results
09/05/2025
Discover everything you need to know about PhenQ in our detailed 2025 review. We break down the key ingredients, potential side effects, and the real results users have experienced. Is it the ultimate weight loss [...]
Merus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités
09/05/2025
- Essai de phase II portant sur le pétosemtamab en association avec le pembrolizumab en 1re ligne de traitement dans le CETC r/m exprimant PD-L1 en cours et données cliniques mises à jour lors de la réunion annuelle [...]
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
09/05/2025
COPENHAGEN, Denmark, May 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial [...]
Akero Therapeutics Presents Week 96 Results from Phase 2b SYMMETRY Clinical Trial of Efruxifermin in Patients with Compensated Cirrhosis Caused by MASH Showing Fibrosis Improvement without Worsening of MASH at the EASL Congress 2025
09/05/2025
SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked [...]
ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance
09/05/2025
Generated record quarterly net revenues of $197.1 million, representing year-over-year growth of 43.4% Total Rare Disease quarterly net revenues of $69.0 million, which includes: Purified Cortrophin® Gel net revenues of [...]
Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab
09/05/2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
Real-World Study Confirms Long-Term Performance of DecisionDx®-UM for Metastatic Risk Stratification in Uveal Melanoma and Utility of PRAME Biomarker for Refining Risk When Considered with the DecisionDx-UM Class Result
09/05/2025
FRIENDSWOOD, Texas, May 09, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data from the first [...]
Vireo Growth Inc. Announces First Quarter 2025 Results
09/05/2025
– Q1 revenue of $24.5 million increased 1.9% year-over-year, in line with expectations for Vireo’s established markets – – Merger Transactions expected to begin closing in Q2 and further strengthen profitability profile [...]
InspireMD Reports First Quarter 2025 Financial Results
09/05/2025
Management to host investor conference call today, May 9th, at 8:30am ET MIAMI, May 09, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of [...]
Kymera Therapeutics Announces First Quarter 2025 Financial Results and Provides a Business Update
09/05/2025
Completed KT-621 (STAT6) SAD/MAD Phase 1 healthy volunteer trial with data to be reported in June 2025 First patient dosed in KT-621 (STAT6) BroADen Phase 1b trial in moderate to severe atopic dermatitis (AD) with data [...]
Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights
09/05/2025
Initial proof-of-concept data from the ongoing BBI-355 Phase 1/2 POTENTIATE trial in patients with oncogene-amplified cancers anticipated in the second half of 2025 Novel Kinesin program on track for mid-2025 [...]
Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025
09/05/2025
CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its [...]
OXB to Present at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
09/05/2025
OXB to Present at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) Oxford, UK – 9 May 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces [...]
Aclaris Therapeutics to Participate in the HC Wainwright “HCW@Home” Series
09/05/2025
WAYNE, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]
Rapid Micro Biosystems Reports First Quarter 2025 Financial Results
09/05/2025
Reports first quarter 2025 total revenue of $7.2 million , representing 28% growth compared to the first quarter of 2024. Reports record quarterly service revenue led by strong validation activity. Reports first quarter [...]

Pages